NONMEM Users Network Archive

Hosted by Cognigen

job offer Pharmacometrics Bayer Germany

From: Dirk Garmann <dirk.garmann>
Date: Wed, 24 Apr 2019 13:40:21 +0000

Dear all,
Clinical Pharmacometrics at Bayer is now hiring a Modeling and Simulation E=
xpert, located in Wuppertal (close to Cologne/Düsseldorf), Germany.
If you are a highly motivated and enthusiastic scientist, the following pos=
ition might be of interest for you:

The M&S Expert at Bayer provides population PK/PD modeling support in all t=
herapeutic areas from early development to market.
Together with the Pharmacometric Lead, he/she drives model based drug devel=
opment strategies.
The key task of the M&S Expert is to develop and establish complex pharmaco=
kinetic and -dynamic models in order to answer drug development related que=
stions, e.g by simulations.
He/she is responsible for the assessment of pharmacological plausibility of=
 population PK/PD M&S results, provides regulatory knowledge in all stages =
of drug development and ensures compliance with regulations and guidance's =
of regulatory authorities.

We offer a competitive salary in an international environment as well as ex=
cellent opportunities for professional and personal development.
If you are interested, please use the link to the web posting and online ap=

Freundliche Grüße / Best regards,

Dr. Dirk Garmann
Head of Quantitative Pharmacology


Bayer AG
Research & Development, Pharmaceuticals
Quantitative Pharmacology
Building 0431, 322
42096 Wuppertal, Germany
Tel: +49 202 36-5577
Mobile: +49 175 3109407
E-mail: dirk.garmann
aehlte-verarbeitungstaetigkeiten.aspx> // Data privacy information<https://=

/// Vorstand: Werner Baumann, Vorsitzender | Liam Condon, Hartmut Klusik, K=
emal Malik, Wolfgang Nickl, Stefan Oelrich, Heiko Schipper
/// Vorsitzender des Aufsichtsrats: Werner Wenning
/// Sitz der Gesellschaft: Leverkusen | Amtsgericht Köln, HRB 48248

Received on Wed Apr 24 2019 - 09:40:21 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: